[HTML] nature.com

[HTML][HTML] Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer

WCH Visser, H de Jong, S Steyaert… - Prostate Cancer and …, 2022 - nature.com
Background Molecular biomarker tests are developed as diagnostic tools for prostate cancer
(PCa) diagnosis. The SelectMDx (MDxHealth, Nijmegen, The Netherlands) test is a urinary …
被引用次数：14 相关文章
[HTML] nih.gov

[HTML][HTML] Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer

WCH Visser, H de Jong, S Steyaert… - Prostate Cancer and …, 2022 - ncbi.nlm.nih.gov
Background Molecular biomarker tests are developed as diagnostic tools for prostate cancer
(PCa) diagnosis. The SelectMDx (MDxHealth, Nijmegen, The Netherlands) test is a urinary …
[PDF] ru.nl

[PDF][PDF] Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer

WCH Visser, H Jong, S Steyaert, WJG Melchers… - 2022 - repository.ubn.ru.nl
BACKGROUND: Molecular biomarker tests are developed as diagnostic tools for prostate
cancer (PCa) diagnosis. The SelectMDx (MDxHealth, Nijmegen, The Netherlands) test is a …

Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer.

WCH Visser, H de Jong, S Steyaert… - Prostate Cancer and …, 2022 - europepmc.org
Background Molecular biomarker tests are developed as diagnostic tools for prostate cancer
(PCa) diagnosis. The SelectMDx (MDxHealth, Nijmegen, The Netherlands) test is a urinary …

Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer

WCH Visser, H de Jong, S Steyaert… - Prostate cancer …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Molecular biomarker tests are developed as diagnostic tools for prostate cancer
(PCa) diagnosis. The SelectMDx (MDxHealth, Nijmegen, The Netherlands) test is a urinary …